Navigation Links
Vermillion to Present at the 2012 Gateway Conference on September 6
Date:8/28/2012

AUSTIN, Texas, Aug. 28, 2012 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a leading molecular diagnostics company, has been invited to present at the 2012 Gateway Conference being held on September 6 at the W San Francisco Hotel.

Vermillion management is scheduled to present at 11:00 a.m. Pacific time, with one-on-one meetings held throughout the day. As the first FDA-cleared blood test for pre-surgical cancer diagnosis of ovarian tumors by using a unique multi-biomarker approach, management will discuss the company's progress in making OVA1® the standard of care in the diagnosis of ovarian cancer.

To schedule a one-on-one meeting, visit www.gateway-conference.com and click on the Register/Login tab. You may also email your request to schedule@gateway-conference.com or call Ron Both at (949) 574-3860.

About the Gateway Conference
Gateway Conference is designed to provide a unique gateway between influential members of the investment community and a select group of compelling publicly-traded companies. Portfolio managers, research analysts and brokers from buy-side and sell-side institutions will have the opportunity to learn about more than 50 emerging growth companies across a broad range of industries, from technology, business services and digital media, to clean-tech, consumer/retail, life sciences and natural resources.  For more information, go to www.gateway-conference.com.

The invitation-only conference is hosted by Liolios Group, one of the nation's top investor relations agencies, and sponsored by leading firms that service the financial community. For more information about Liolios Group, visit www.liolios.com.

About Vermillion
Vermillion, Inc. (NASDAQ: VRML) is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its prestigious scientific collaborators, has diagnostic programs in oncology, vascular medicine and women's health. Additional information about Vermillion can be found at www.vermillion.com.

Investor Relations Contact:
Liolios Group
Scott Liolios or Ron Both
Tel 949-574-3860
vrml@liolios.com


'/>"/>
SOURCE Vermillion, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Vermillion Sets First Quarter 2012 Conference Call for Tuesday, May 15, 2012 at 4:30 p.m. ET
2. Vermillion Announces CEO Succession Plan
3. Vermillion PAD Intended Use Study Presented at Society for Vascular Medicine 23rd Annual Scientific Sessions
4. Vermillion Announces Positive Top-Line Results from the OVA500 Multi-Center Study Led by UC Irvine
5. Vermillion Reports Second Quarter 2012 Results
6. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
7. Latest Findings in Breastfeeding Science Presented at Medelas 7th International Breastfeeding and Lactation Symposium
8. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
9. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
10. Foundation for Managed Care Pharmacy (FMCP) Presents Awards for 2012 National P&T Competition and Best Posters
11. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/5/2020)... ... August 04, 2020 , ... ... therapy services vital to their health and quality of life unless Congress and ... American Speech-Language-Hearing Association (ASHA) warns today. , At issue is ...
(Date:8/3/2020)... ... August 03, 2020 , ... Hide-a-Mask, a hat with ... over $36,000 in less than three weeks since launch. Hide-a-Mask is ideal for anyone ... for our early backers who, like us, believe having a mask at your fingertips ...
(Date:7/31/2020)... ... July 31, 2020 , ... Member Care Solutions announced a deal ... care clinic operators the licensing of their cloud based membership management software platform. , ... client family. Our software is the perfect match for many reasons, but AFC’s need ...
Breaking Medicine Technology:
(Date:7/31/2020)... (PRWEB) , ... July 31, 2020 , ... ... visited Meridian Clinical Research’s internal medicine site in Savannah, GA. Visitors ... of OWS. , In May, the federal government announced the OWS program to ...
(Date:7/31/2020)... ... July 31, 2020 , ... National Association of Chain Drug ... regarding the nation’s ongoing preparations for the eventual deployment of COVID-19 vaccines: , ... effective and essential component of vaccine deployment. They will need to be part ...
(Date:7/22/2020)... ... July 22, 2020 , ... With Covid-19 and the ... world has changed, and there’s no going back. In confronting our discomfort during ... us temporarily manage emotional struggles, healing is the approach we should strive for. ...
(Date:7/22/2020)... ... 2020 , ... Healthcare data curation and enrichment company ... Service (DCaaS) solution for payers, providers, healthcare systems, and OEM partners.? , ... are custom tailored to provide clients a clear, trusted, comprehensive data curation and ...
(Date:7/18/2020)... ... 17, 2020 , ... “Frozen.” It’s not simply the title of a popular ... unknown reasons – resulting in stiffness, persistent pain and loss of range of motion. ... of the upper limbs and joints and founder and chief medical officer of the ...
Breaking Medicine News(10 mins):